SSA
CTOR

Schonfeld Strategic Advisors’s Citius Oncology, Inc. Common Stock CTOR Stock Holding History

Schonfeld Strategic Advisors’s Portfolio CTOR Stock Details CTOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-12,600
Closed -$131K – 2378
2023
Q1 		$131K Buy
+12,600
New +$131K ﹤0.01% 1594